Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Appl Clin Inform ; 11(4): 635-643, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32998170

RESUMEN

BACKGROUND: Although patients who work and have related health issues are usually first seen in primary care, providers in these settings do not routinely ask questions about work. Guidelines to help manage such patients are rarely used in primary care. Electronic health record (EHR) systems with worker health clinical decision support (CDS) tools have potential for assisting these practices. OBJECTIVE: This study aimed to identify the need for, and barriers and facilitators related to, implementation of CDS tools for the clinical management of working patients in a variety of primary care settings. METHODS: We used a qualitative design that included analysis of interview transcripts and observational field notes from 10 clinics in five organizations. RESULTS: We interviewed 83 providers, staff members, managers, informatics and information technology experts, and leaders and spent 35 hours observing. We identified eight themes in four categories related to CDS for worker health (operational issues, usefulness of proposed CDS, effort and time-related issues, and topic-specific issues). These categories were classified as facilitators or barriers to the use of the CDS tools. Facilitators related to operational issues include current technical feasibility and new work patterns associated with the coordinated care model. Facilitators concerning usefulness include users' need for awareness and evidence-based tools, appropriateness of the proposed CDS for their patients, and the benefits of population health data. Barriers that are effort-related include additional time this proposed CDS might take, and other pressing organizational priorities. Barriers that are topic-specific include sensitive issues related to health and work and the complexities of information about work. CONCLUSION: We discovered several themes not previously described that can guide future CDS development: technical feasibility of the proposed CDS within commercial EHRs, the sensitive nature of some CDS content, and the need to assist the entire health care team in managing worker health.


Asunto(s)
Sistemas de Apoyo a Decisiones Clínicas , Salud/estadística & datos numéricos , Evaluación de Necesidades , Atención Primaria de Salud/estadística & datos numéricos , Registros Electrónicos de Salud , Humanos
2.
Int J Med Inform ; 118: 78-85, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30153926

RESUMEN

OBJECTIVE: Developing effective and reliable rule-based clinical decision support (CDS) alerts and reminders is challenging. Using a previously developed taxonomy for alert malfunctions, we identified best practices for developing, testing, implementing, and maintaining alerts and avoiding malfunctions. MATERIALS AND METHODS: We identified 72 initial practices from the literature, interviews with subject matter experts, and prior research. To refine, enrich, and prioritize the list of practices, we used the Delphi method with two rounds of consensus-building and refinement. We used a larger than normal panel of experts to include a wide representation of CDS subject matter experts from various disciplines. RESULTS: 28 experts completed Round 1 and 25 completed Round 2. Round 1 narrowed the list to 47 best practices in 7 categories: knowledge management, designing and specifying, building, testing, deployment, monitoring and feedback, and people and governance. Round 2 developed consensus on the importance and feasibility of each best practice. DISCUSSION: The Delphi panel identified a range of best practices that may help to improve implementation of rule-based CDS and avert malfunctions. Due to limitations on resources and personnel, not everyone can implement all best practices. The most robust processes require investing in a data warehouse. Experts also pointed to the issue of shared responsibility between the healthcare organization and the electronic health record vendor. CONCLUSION: These 47 best practices represent an ideal situation. The research identifies the balance between importance and difficulty, highlights the challenges faced by organizations seeking to implement CDS, and describes several opportunities for future research to reduce alert malfunctions.


Asunto(s)
Sistemas de Apoyo a Decisiones Clínicas/normas , Técnica Delphi , Registros Electrónicos de Salud , Errores Médicos/prevención & control , Guías de Práctica Clínica como Asunto/normas , Consenso , Humanos
3.
J Am Med Inform Assoc ; 25(5): 496-506, 2018 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-29045651

RESUMEN

Objective: To develop an empirically derived taxonomy of clinical decision support (CDS) alert malfunctions. Materials and Methods: We identified CDS alert malfunctions using a mix of qualitative and quantitative methods: (1) site visits with interviews of chief medical informatics officers, CDS developers, clinical leaders, and CDS end users; (2) surveys of chief medical informatics officers; (3) analysis of CDS firing rates; and (4) analysis of CDS overrides. We used a multi-round, manual, iterative card sort to develop a multi-axial, empirically derived taxonomy of CDS malfunctions. Results: We analyzed 68 CDS alert malfunction cases from 14 sites across the United States with diverse electronic health record systems. Four primary axes emerged: the cause of the malfunction, its mode of discovery, when it began, and how it affected rule firing. Build errors, conceptualization errors, and the introduction of new concepts or terms were the most frequent causes. User reports were the predominant mode of discovery. Many malfunctions within our database caused rules to fire for patients for whom they should not have (false positives), but the reverse (false negatives) was also common. Discussion: Across organizations and electronic health record systems, similar malfunction patterns recurred. Challenges included updates to code sets and values, software issues at the time of system upgrades, difficulties with migration of CDS content between computing environments, and the challenge of correctly conceptualizing and building CDS. Conclusion: CDS alert malfunctions are frequent. The empirically derived taxonomy formalizes the common recurring issues that cause these malfunctions, helping CDS developers anticipate and prevent CDS malfunctions before they occur or detect and resolve them expediently.


Asunto(s)
Sistemas de Apoyo a Decisiones Clínicas , Análisis de Falla de Equipo , Sistemas de Entrada de Órdenes Médicas , Clasificación , Falla de Equipo/estadística & datos numéricos , Humanos , Sistemas de Registros Médicos Computarizados , Estados Unidos
4.
AMIA Annu Symp Proc ; 2016: 285-294, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-28269822

RESUMEN

To determine how the Rapid Assessment Process (RAP) can be adapted to evaluate the readiness of primary care clinics for acceptance and use of computerized clinical decision support (CDS) related to clinical management of working patients, we used a unique blend of ethnographic methods for gathering data. First, knowledge resources, which were prototypes of CDS content areas (diabetes, lower back pain, and asthma) containing evidence-based information, decision logic, scenarios and examples of use, were developed by subject matter experts. A team of RAP researchers then visited five clinic settings to identify barriers and facilitators to implementing CDS about the health of workers in general and the knowledge resources specifically. Methods included observations, semi-structured qualitative interviews and graphic elicitation interviews about the knowledge resources. We used both template and grounded hermeneutic approaches to data analysis. Preliminary results indicate that the methods succeeded in generating specific actionable recommendations for CDS design.


Asunto(s)
Antropología Cultural/métodos , Actitud del Personal de Salud , Actitud hacia los Computadores , Sistemas de Apoyo a Decisiones Clínicas , Entrevistas como Asunto , Sistemas de Apoyo a Decisiones Clínicas/organización & administración , Difusión de Innovaciones , Humanos , Observación , Encuestas y Cuestionarios
5.
Cancer Cell ; 25(6): 809-821, 2014 Jun 16.
Artículo en Inglés | MEDLINE | ID: mdl-24909985

RESUMEN

B cells foster squamous cell carcinoma (SCC) development through deposition of immunoglobulin-containing immune complexes in premalignant tissue and Fcγ receptor-dependent activation of myeloid cells. Because human SCCs of the vulva and head and neck exhibited hallmarks of B cell infiltration, we examined B cell-deficient mice and found reduced support for SCC growth. Although ineffective as a single agent, treatment of mice bearing preexisting SCCs with B cell-depleting αCD20 monoclonal antibodies improved response to platinum- and Taxol-based chemotherapy. Improved chemoresponsiveness was dependent on altered chemokine expression by macrophages that promoted tumor infiltration of activated CD8(+) lymphocytes via CCR5-dependent mechanisms. These data reveal that B cells, and the downstream myeloid-based pathways they regulate, represent tractable targets for anticancer therapy in select tumors.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Linfocitos B/inmunología , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/inmunología , Macrófagos/inmunología , Neoplasias/tratamiento farmacológico , Neoplasias/inmunología , Animales , Linfocitos B/efectos de los fármacos , Linfocitos B/patología , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/patología , Células CHO , Carcinoma de Células Escamosas/patología , Cricetulus , Femenino , Humanos , Linfocitos Infiltrantes de Tumor/inmunología , Linfocitos Infiltrantes de Tumor/patología , Macrófagos/efectos de los fármacos , Macrófagos/patología , Ratones , Ratones Transgénicos , Neoplasias/patología , Compuestos Organoplatinos/administración & dosificación , Paclitaxel/administración & dosificación , Fenotipo , Microambiente Tumoral , Ensayos Antitumor por Modelo de Xenoinjerto
6.
Dis Model Mech ; 3(5-6): 317-32, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20223936

RESUMEN

Innate regulatory networks within organs maintain tissue homeostasis and facilitate rapid responses to damage. We identified a novel pathway regulating vessel stability in tissues that involves matrix metalloproteinase 14 (MMP14) and transforming growth factor beta 1 (TGFbeta(1)). Whereas plasma proteins rapidly extravasate out of vasculature in wild-type mice following acute damage, short-term treatment of mice in vivo with a broad-spectrum metalloproteinase inhibitor, neutralizing antibodies to TGFbeta(1), or an activin-like kinase 5 (ALK5) inhibitor significantly enhanced vessel leakage. By contrast, in a mouse model of age-related dermal fibrosis, where MMP14 activity and TGFbeta bioavailability are chronically elevated, or in mice that ectopically express TGFbeta in the epidermis, cutaneous vessels are resistant to acute leakage. Characteristic responses to tissue damage are reinstated if the fibrotic mice are pretreated with metalloproteinase inhibitors or TGFbeta signaling antagonists. Neoplastic tissues, however, are in a constant state of tissue damage and exhibit altered hemodynamics owing to hyperleaky angiogenic vasculature. In two distinct transgenic mouse tumor models, inhibition of ALK5 further enhanced vascular leakage into the interstitium and facilitated increased delivery of high molecular weight compounds into premalignant tissue and tumors. Taken together, these data define a central pathway involving MMP14 and TGFbeta that mediates vessel stability and vascular response to tissue injury. Antagonists of this pathway could be therapeutically exploited to improve the delivery of therapeutics or molecular contrast agents into tissues where chronic damage or neoplastic disease limits their efficient delivery.


Asunto(s)
Vasos Sanguíneos/enzimología , Vasos Sanguíneos/patología , Metaloproteinasa 14 de la Matriz/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Envejecimiento/patología , Animales , Colágenos Fibrilares/metabolismo , Homeostasis , Metaloproteinasa 14 de la Matriz/deficiencia , Ratones , Modelos Biológicos , Planta de la Mostaza , Aceites de Plantas , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Proteínas Serina-Treonina Quinasas/metabolismo , Receptor Tipo I de Factor de Crecimiento Transformador beta , Receptores de Factores de Crecimiento Transformadores beta/antagonistas & inhibidores , Receptores de Factores de Crecimiento Transformadores beta/metabolismo , Neoplasias Cutáneas/irrigación sanguínea , Neoplasias Cutáneas/patología , Células del Estroma/enzimología , Células del Estroma/patología , Resistencia Vascular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...